BNIP3 and malignant glioma: Nuclear BNIP3 has been shown to acts as a transcriptional repressor to reduce apoptosis-inducing factor expression and increase resistance to apoptosis in human malignant gliomas (Burton, Eisenstat & Gibson, 2009).